We are pleased to announce that DuoGenic StemCells Co. has made an agreement with Symphony Biomedicine Co. Ltd., effective from 01, November 2024. Symphony Biomedicine is […]
A new way to treat joint diseases could follow from the first demonstration of using immune cells to produce collagen. In a promising development for treating […]
Osteoarthritis is an arch-enemy of the elders. The prevalence rate of knee osteoarthritis in Taiwan is about 15%, and over 3.5 million people suffer from joint […]